---
title: "Yonghe Medical Group Co., Ltd. (02279.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02279.HK.md"
symbol: "02279.HK"
name: "Yonghe Medical Group Co., Ltd."
industry: "Health Care Facilities"
---

# Yonghe Medical Group Co., Ltd. (02279.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Facilities |
| Location | HK Market |
| Website | [www.yonghegroup.cn](https://www.yonghegroup.cn) |

## Company Profile

Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig bus...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:10.000Z

**Overall: C (0.56)**

**Industry**: Health Care Facilities

| Metric | Value |
|--------|-------|
| Industry Ranking | 8 / 18 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -4.39% |  |
| Net Profit YoY | 87.08% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.29 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.05B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.91B |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -7.75% | D |
| Profit Margin | -3.39% | D |
| Gross Margin | 63.88% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -4.39% | D |
| Net Profit YoY | 87.08% | A |
| Total Assets YoY | -21.19% | E |
| Net Assets YoY | -5.78% | D |

#### Cash Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -2950.06% | E |
| OCF YoY | -4.39% | D |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.95 | A |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 54.06% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Yonghe Medical Group Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-7.75%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-3.39%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "63.88%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-4.39%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "87.08%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-21.19%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-5.78%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "E",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-2950.06%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-4.39%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.95",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "54.06%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | SAINT BELLA (HK.2508) | D | A | B | B | B | B |
| 02 | HYGEIA HEALTH (HK.6078) | C | D | C | B | C | C |
| 03 | BAYZED HEALTH (HK.2609) | D | C | C | B | D | C |
| 04 | CR MEDICAL (HK.1515) | C | C | B | C | C | C |
| 05 | CHAOJU EYE CARE (HK.2219) | B | D | C | A | C | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.00 | 18/19 | - | - | - |
| PB | 1.29 | 15/19 | 1.50 | 1.11 | 0.71 |
| PS (TTM) | 0.54 | 9/19 | 0.61 | 0.46 | 0.29 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-04-02T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.00 |
| Highest Target | 1.60 |
| Lowest Target | 1.60 |

## References

- [Company Overview](https://longbridge.com/en/quote/02279.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02279.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02279.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.